Edition:
United Kingdom

Cellectis SA (ALCLS.PA)

ALCLS.PA on Paris Stock Exchange

19.08EUR
16 Nov 2018
Change (% chg)

€-1.22 (-6.01%)
Prev Close
€20.30
Open
€19.99
Day's High
€20.08
Day's Low
€19.08
Volume
131,811
Avg. Vol
52,241
52-wk High
€29.78
52-wk Low
€19.08

Select another date:

Wed, Nov 14 2018

BRIEF-Cellectis Reports End-Sept Cash Of 475.9 Million Dollars

* REPORTED ON TUESDAY TOTAL CASH, CASH EQUIVALENTS AND CURRENT FINANCIAL ASSETS $475.9 MILLION AS OF SEPTEMBER 30, 2018

BRIEF-Cellectis Operating Loss Widens To 21.7 Million US Dollars

* SAID ON WEDNESDAY ITS Q2 REVENUES WERE $5.0 MLN VS $6.5 MLN YEAR AGO

BRIEF-Cellectis Publishes Methods to Improve Clinical Use of Chimeric Antigen Receptor T-Cell Therapy

* ANNOUNCED ON TUESDAY NOVEL METHODS TO IMPROVE THE CLINICAL USE OF CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY

BRIEF-Cellectis Announces Approval Of Amendment To Protocol For UCART123 Phase 1 Clinical Trial

* ANNOUNCED ON TUESDAY APPROVAL OF AMENDMENT TO PROTOCOL FOR PHASE 1 CLINICAL TRIAL OF UCART123 PRODUCT CANDIDATE IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS

Select another date: